ID
13577
Description
Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00093990
Link
https://clinicaltrials.gov/show/NCT00093990
Keywords
Versions (1)
- 2/17/16 2/17/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
February 17, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Myeloid Leukemia NCT00093990
Eligibility Acute Myeloid Leukemia NCT00093990
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
previous cytotoxic or biologic treatment for aml
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0677881
- UMLS CUI [2]
- C0278947
- UMLS CUI [3]
- C0023467
Description
acute promyelocytic leukemia (apl)
Data type
boolean
Alias
- UMLS CUI [1]
- C0023487
Description
central nervous system leukemia
Data type
boolean
Alias
- UMLS CUI [1]
- C1332884
Description
uncontrolled systemic infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
uncompensated disseminated intravascular coagulation
Data type
boolean
Alias
- UMLS CUI [1]
- C0012739
Description
symptomatic neuropathy of grade 2 or worse
Data type
boolean
Alias
- UMLS CUI [1]
- C0442874
Description
known allergy to imidazole drugs.
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0020923
Similar models
Eligibility Acute Myeloid Leukemia NCT00093990
- StudyEvent: Eligibility
C0392920 (UMLS CUI [1,2])
C0521091 (UMLS CUI [1,2])
C0023467 (UMLS CUI [1,3])
C0677881 (UMLS CUI [1,2])
C0278947 (UMLS CUI [2])
C0023467 (UMLS CUI [3])
C0020923 (UMLS CUI [1,2])